IRIDEX Corporation (IRIX)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $12.12M
Last updated: Nov 17, 2026 at 10:43 AM ET
IRIDEX Corporation (IRIX) Earnings: Report Dates and Results
IRIDEX (IRIX) is confirmed to report earnings on Nov 17, 2026, after the close. In the quarter ended Jun 30, 2026, IRIDEX reported EPS of -$0.07, below the -$0.01 estimate. It beat the EPS estimate in 4 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
IRIX has a confirmed report date of Nov 17, 2026, after the close.
IRIX Earnings Call
The latest IRIX earnings call transcript on file is labeled 2026Q2.
Read the 2026Q2 transcriptEarnings History
Of the 40 quarters below that had an estimate, IRIX beat 22, missed 16 and matched 2. Revenue for the quarter ended Jun 30, 2026 was $12.57M, down 7.4% from $13.57M a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | -$0.07 | -$0.01 | -$0.01 - -$0.01 | -600.00% | Miss | N/A | 1 | 1 up, 0 down | Aug 18, 2026 | $12.57M |
| Mar 31, 2026 | -$0.03 | -$0.07 | -$0.07 - -$0.07 | +57.14% | Beat | N/A | 1 | 0 up, 1 down | May 19, 2026 | $11.80M |
| Dec 31, 2025 | -$0.01 | -$0.02 | N/A | +46.50% | Beat | N/A | N/A | N/A | Mar 26, 2026 | $14.72M |
| Sep 30, 2025 | -$0.09 | -$0.06 | N/A | -50.00% | Miss | N/A | N/A | N/A | Nov 11, 2025 | $12.48M |
| Jun 30, 2025 | -$0.06 | -$0.09 | N/A | +33.33% | Beat | N/A | N/A | N/A | Aug 12, 2025 | $13.57M |
| Mar 31, 2025 | -$0.10 | -$0.12 | N/A | +16.00% | Beat | N/A | N/A | 1 up, 0 down | May 13, 2025 | $11.90M |
| Dec 31, 2024 | -$0.05 | -$0.05 | N/A | -0.20% | Miss | N/A | N/A | 1 up, 0 down | Mar 27, 2025 | $12.70M |
| Sep 30, 2024 | -$0.12 | -$0.09 | N/A | -33.33% | Miss | N/A | N/A | 1 up, 0 down | Nov 12, 2024 | $11.58M |
| Jun 30, 2024 | -$0.16 | -$0.12 | -$0.12 - -$0.12 | -33.33% | Miss | N/A | 1 | 0 up, 0 down | Aug 8, 2024 | $12.63M |
| Mar 31, 2024 | -$0.21 | -$0.12 | -$0.12 - -$0.12 | -75.00% | Miss | N/A | 1 | 0 up, 0 down | May 14, 2024 | $11.76M |
| Dec 31, 2023 | -$0.18 | -$0.05 | -$0.05 - -$0.05 | -260.00% | Miss | N/A | 1 | 0 up, 0 down | Mar 26, 2024 | $12.46M |
| Sep 30, 2023 | -$0.11 | -$0.12 | -$0.14 - -$0.11 | +8.33% | Beat | N/A | 2 | 0 up, 0 down | Nov 14, 2023 | $12.85M |
| Jun 30, 2023 | -$0.17 | -$0.11 | -$0.12 - -$0.10 | -54.55% | Miss | N/A | 2 | 0 up, 0 down | Aug 10, 2023 | $12.86M |
| Mar 31, 2023 | -$0.13 | -$0.12 | -$0.13 - -$0.11 | -8.33% | Miss | N/A | 2 | 0 up, 0 down | May 11, 2023 | $13.71M |
| Dec 31, 2022 | -$0.07 | -$0.11 | -$0.11 - -$0.11 | +36.36% | Beat | N/A | 2 | 0 up, 0 down | Mar 9, 2023 | $15.20M |
| Sep 30, 2022 | -$0.11 | -$0.14 | -$0.16 - -$0.13 | +21.43% | Beat | N/A | 2 | 0 up, 0 down | Nov 10, 2022 | $14.63M |
| Jun 30, 2022 | -$0.14 | -$0.15 | -$0.17 - -$0.14 | +6.67% | Beat | -255.6% | 2 | 0 up, 0 down | Aug 15, 2022 | $13.76M |
| Mar 31, 2022 | -$0.15 | -$0.16 | -$0.18 - -$0.14 | +6.25% | Beat | N/A | 2 | 0 up, 0 down | May 12, 2022 | $13.39M |
| Dec 31, 2021 | -$0.15 | -$0.11 | -$0.11 - -$0.11 | -36.36% | Miss | N/A | 2 | N/A | Mar 10, 2022 | $15.25M |
| Sep 30, 2021 | -$0.14 | -$0.14 | -$0.16 - -$0.13 | 0.00% | In line | N/A | 2 | N/A | Nov 11, 2021 | $13.26M |
| Jun 30, 2021 | $0.09 | -$0.15 | -$0.16 - -$0.15 | +160.00% | Beat | N/A | 2 | N/A | Aug 12, 2021 | $13.43M |
| Mar 31, 2021 | -$0.14 | -$0.14 | -$0.15 - -$0.13 | 0.00% | In line | N/A | 2 | N/A | May 11, 2021 | $11.96M |
| Dec 31, 2020 | -$0.01 | -$0.10 | -$0.17 - -$0.04 | +90.00% | Beat | N/A | 2 | N/A | Mar 22, 2021 | $12.30M |
| Sep 30, 2020 | -$0.12 | -$0.17 | -$0.18 - -$0.17 | +29.41% | Beat | N/A | 2 | N/A | Nov 9, 2020 | $8.80M |
| Jun 30, 2020 | -$0.20 | -$0.22 | -$0.24 - -$0.21 | +9.09% | Beat | N/A | 2 | N/A | Aug 6, 2020 | $6.22M |
| Mar 31, 2020 | -$0.12 | -$0.19 | -$0.19 - -$0.14 | +36.84% | Beat | N/A | 2 | N/A | May 11, 2020 | $9.02M |
| Dec 31, 2019 | -$0.11 | -$0.15 | -$0.17 - -$0.14 | +26.67% | Beat | N/A | 2 | N/A | Mar 12, 2020 | $11.76M |
| Sep 30, 2019 | -$0.13 | -$0.19 | -$0.19 - -$0.16 | +31.58% | Beat | N/A | 2 | N/A | Nov 7, 2019 | $10.66M |
| Jun 30, 2019 | -$0.18 | -$0.22 | -$0.22 - -$0.22 | +18.18% | Beat | N/A | 2 | N/A | Aug 6, 2019 | $10.43M |
| Mar 31, 2019 | -$0.22 | -$0.24 | -$0.25 - -$0.23 | +8.33% | Beat | N/A | 2 | N/A | May 2, 2019 | $10.60M |
| Dec 31, 2018 | -$0.21 | -$0.24 | -$0.25 - -$0.24 | +12.50% | Beat | N/A | 2 | N/A | Mar 5, 2019 | $11.47M |
| Sep 30, 2018 | -$0.26 | -$0.28 | -$0.29 - -$0.28 | +7.14% | Beat | N/A | 2 | N/A | Nov 1, 2018 | $11.32M |
| Jun 30, 2018 | -$0.28 | -$0.32 | -$0.32 - -$0.32 | +12.50% | Beat | N/A | 1 | N/A | Aug 2, 2018 | $10.30M |
| Mar 31, 2018 | -$0.31 | -$0.33 | -$0.33 - -$0.33 | +6.06% | Beat | N/A | 1 | N/A | May 3, 2018 | $9.51M |
| Dec 31, 2017 | -$0.44 | -$0.27 | -$0.27 - -$0.27 | -62.96% | Miss | N/A | 1 | N/A | Mar 8, 2018 | $10.24M |
| Sep 30, 2017 | -$0.28 | -$0.15 | -$0.28 - -$0.15 | -86.67% | Miss | N/A | 2 | N/A | Nov 2, 2017 | $10.87M |
| Jun 30, 2017 | -$0.24 | -$0.12 | -$0.18 - -$0.06 | -100.00% | Miss | -2500.0% | 2 | N/A | Aug 3, 2017 | $10.00M |
| Mar 31, 2017 | -$0.16 | -$0.12 | N/A | -33.33% | Miss | -1700.0% | N/A | N/A | May 3, 2017 | $10.48M |
| Dec 31, 2016 | -$1.03 | -$0.12 | N/A | -758.33% | Miss | -2675.0% | N/A | N/A | Mar 8, 2017 | $12.53M |
| Sep 30, 2016 | -$0.07 | -$0.03 | N/A | -133.33% | Miss | -275.0% | N/A | N/A | Nov 3, 2016 | $9.79M |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$0.26, after -$0.54 the year before. It was -$1.08 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$0.26 | N/A |
| Dec 31, 2024 | -$0.54 | N/A |
| Dec 31, 2023 | -$0.59 | N/A |
| Dec 31, 2022 | -$0.47 | N/A |
| Dec 31, 2021 | -$0.34 | N/A |
| Dec 31, 2020 | -$0.45 | N/A |
| Dec 31, 2019 | -$0.64 | N/A |
| Dec 31, 2018 | -$1.06 | N/A |
| Dec 31, 2017 | -$1.12 | N/A |
| Dec 31, 2016 | -$1.08 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q2 for the period ended Jun 30, 2026, runs about 3,500 words across 5 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q2 | Jun 30, 2026 | 3,513 | 5 | |
| 2026Q1 | Mar 31, 2026 | 3,756 | 5 | |
| 2025Q4 | Dec 31, 2025 | 3,425 | 5 | |
| 2025Q3 | Sep 30, 2025 | 2,132 | 4 | |
| 2025Q2 | Jun 30, 2025 | 2,084 | 4 | |
| 2025Q1 | Mar 31, 2025 | 2,354 | 4 | |
| 2024Q3 | Sep 30, 2024 | 2,677 | 4 | |
| 2024Q2 | Jun 30, 2024 | 2,586 | 5 |
2026Q2 Earnings Call
Opening remarks
Trip Taylor Investor Relations Thank you, operator. Thank you all for joining us this afternoon. With me on today's call are Patrick Mercer, IRIDEX's Chief Executive Officer, and Romeo R. Dizon, the company's Chief Financial Officer. Earlier today, IRIDEX issued a press release detailing our financial results for the quarter ended 07/04/2026, which is posted to the Investors section of our website. Before we begin, I would like to remind you that management will make statements during this call that include forward-looking statements within the meaning of federal securities laws, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements made during this call that are not statements of historical fact, including, but not limited to, statements concerning our strategic goals and priorities, product development matters, sales trends, and the markets in which we operate, are forward-looking. All forward-looking statements are based upon our current estimates and various assumptions. These statements involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated or implied by these forward-looking statements. Accordingly, you should not place reliance on these statements. For a discussion of the risks and uncertainties associated with our business, please see the most recent Form 10-K and Form 10-Q filings with the SEC. IRIDEX disclaims any intention or obligation, except as required by law, to update or revise any financial projections or forward-looking statements, whether because of new information, future events, or otherwise. This conference call contains time-sensitive information and is accurate only as of the live broadcast today, August 18, 2026. With that, I will pass the call to Patrick.
Patrick Mercer Chief Executive Officer Good afternoon, everyone, and thank you for joining us for our second quarter call. If there is one message I want to leave you with today, it is that IRIDEX has reached an important inflection point in its financial profile. We generated positive cash flow in the second quarter demonstrating the meaningful progress we have made over the past two years to fundamentally transform our cost structure, strengthen working capital management and create a more disciplined and sustainable business. As part of our activity to further improve the efficiency of the business, this month we began the process of relocating our headquarters. This is a long-anticipated cost-cutting step and an important part of our broader effort to optimize our cost structure, improve operational efficiency, and align our infrastructure with the business we are building for the future. The headquarters move will require a new registration process and managing global registration blackout periods in order to secure our international supply chain and protect top-line distributor revenue streams.
Frequently Asked Questions About IRIX
When is IRIDEX's next earnings date?
IRIDEX's next earnings report is confirmed for Nov 17, 2026, after the close.
Did IRIX beat earnings estimates last quarter?
No. IRIDEX reported EPS of -$0.07 for the quarter ended Jun 30, 2026, below the -$0.01 estimate by 600.00%.
What EPS do analysts expect from IRIX next quarter?
The consensus EPS estimate for IRIDEX for the quarter ended Sep 30, 2026 is -$0.04 from 1 analyst, with estimates from -$0.04 to -$0.04.
How often does IRIX beat earnings estimates?
IRIDEX beat the EPS estimate in 4 of the last 8 quarters, with an average surprise of -66.32%.
Does IRIX report before or after the market opens?
IRIDEX is confirmed to report on Nov 17, 2026, after the market closes.
IRIX pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts